Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $42.3 million.

  • Profound Medical's Liabilities and Shareholders Equity rose 98.35% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.1 million, marking a year-over-year increase of 1583.29%. This contributed to the annual value of $70.2 million for FY2024, which is 5978.25% up from last year.
  • Latest data reveals that Profound Medical reported Liabilities and Shareholders Equity of $42.3 million as of Q3 2025, which was up 98.35% from $49.7 million recorded in Q2 2025.
  • Over the past 5 years, Profound Medical's Liabilities and Shareholders Equity peaked at $70.2 million during Q4 2024, and registered a low of $61242.0 during Q1 2023.
  • In the last 3 years, Profound Medical's Liabilities and Shareholders Equity had a median value of $49.7 million in 2024 and averaged $47.5 million.
  • Examining YoY changes over the last 5 years, Profound Medical's Liabilities and Shareholders Equity showed a top increase of 9304032.85% in 2024 and a maximum decrease of 1695.15% in 2024.
  • Profound Medical's Liabilities and Shareholders Equity (Quarter) stood at $44.0 million in 2023, then skyrocketed by 59.78% to $70.2 million in 2024, then plummeted by 39.77% to $42.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $42.3 million for Q3 2025, versus $49.7 million for Q2 2025 and $60.9 million for Q1 2025.